Moriwaki Y, Kamisaki Y, Itoh T, Nagata M, Tamai A
Department of Ophthalmology, Faculty of Medicine, Tottori University, Yonago, Japan.
Jpn J Ophthalmol. 1998 Jul-Aug;42(4):269-74. doi: 10.1016/s0021-5155(98)00009-4.
This study was undertaken to determine whether pathways exist in the rat retina for atrial natriuretic peptide (ANP)-, C-type natriuretic peptide (CNP)-, and nitric oxide (NO)- cyclic 3', 5'-guanosine monophosphate (cGMP). Exposure of the retina to ANP (10(-7) mol/L), CNP (10(-7) mol/L), S-nitroso-N-acetylpenicillamine (10(-5) mol/L, SNAP; a NO donor), A23187 (10(-5)mol/L; a Ca2+ ionophore), and carbachol (10(-3) mol/L) caused 1.45 approximately 1.67-fold increases in cGMP content (P < .01). The increase in cGMP content induced by A23187 was blocked by 2-4-carboxyphenyl . 4455-tetramethyl imidazoline 1-oxyl 3-oxide (10(-3) mol/ L, carboxy-PTIO; a NO scavenger). Both carboxy-PTIO (10(-3) mol/L) and NG-nitro-L-arginine (10(-3) mol/L, L-NNA: a NO synthase inhibitor) blocked the increase in cGMP content induced by carbachol. Atropine (10(-50 mol/L; a muscarinic receptor antagonist) also blocked the cGMP increase induced by carbachol. These data demonstrate that ANP-, CNP-, and NO-cGMP pathways exist in the rat retina and that the NO-cGMP pathway may be linked to the activation of the muscarinic receptor.
本研究旨在确定大鼠视网膜中是否存在心房利钠肽(ANP)、C型利钠肽(CNP)和一氧化氮(NO)-环磷酸鸟苷(cGMP)的信号通路。将视网膜暴露于ANP(10⁻⁷mol/L)、CNP(10⁻⁷mol/L)、S-亚硝基-N-乙酰青霉胺(10⁻⁵mol/L,SNAP;一种NO供体)、A23187(10⁻⁵mol/L;一种Ca²⁺离子载体)和卡巴胆碱(10⁻³mol/L)可使cGMP含量增加1.45至1.67倍(P <.01)。A23187诱导的cGMP含量增加被2-(4-羧基苯基)-4,4,5,5-四甲基咪唑啉-1-氧化物(10⁻³mol/L,羧基-PTIO;一种NO清除剂)阻断。羧基-PTIO(10⁻³mol/L)和NG-硝基-L-精氨酸(10⁻³mol/L,L-NNA:一种NO合酶抑制剂)均可阻断卡巴胆碱诱导的cGMP含量增加。阿托品(10⁻⁵mol/L;一种毒蕈碱受体拮抗剂)也可阻断卡巴胆碱诱导的cGMP增加。这些数据表明,大鼠视网膜中存在ANP-、CNP-和NO-cGMP信号通路,且NO-cGMP信号通路可能与毒蕈碱受体的激活有关。